RGS10 and Parkinson disease: A reduction of RGS10 in immune cells, nonetheless suggests that peripheral immune cells that are capable of directly interacting with the CNS in individuals with PD may lack the ability to negatively regulate the inflammatory response at the same level of healthy controls and may engage hyperinflammatory responses or develop chronic inflammatory responses that endanger vulnerable neuronal populations [48].